Cart
sales@molnova.com
Raloxifene
CAS No. 84449-90-1
Raloxifene( Pharoxifene | Raloxifenum | Keoxifene | LY-139481 )
Catalog No. M24833 CAS No. 84449-90-1
Raloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 56 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 405 | In Stock |
|
| 200MG | 585 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRaloxifene
-
NoteResearch use only, not for human use.
-
Brief DescriptionRaloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
DescriptionRaloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
In Vitro——
-
In VivoRaloxifene (4?mg/kg; intragastrically; daily for 13 weeks) significantly prevents bone loss in ovariectomized (OVX) rats. Animal Model:Female, 12-week-old, Wistar rats (OVX rats) Dosage:4?mg/kg Administration:Intragastrically; daily for 13 weeks Result:Significantly increased the levels of E2 in OVX rats and significantly decreased the levels of BGP.
-
SynonymsPharoxifene | Raloxifenum | Keoxifene | LY-139481
-
PathwayOthers
-
TargetOther Targets
-
RecptorSERM
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84449-90-1
-
Formula Weight473.58
-
Molecular FormulaC28H27NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:90 mg/mL (190.04 mM; Need ultrasonic)；Ethanol:9 mg/mL (19.00 mM; Need ultrasonic)
-
SMILESOc(cc1)ccc1-c1c(C(c(cc2)ccc2OCCN2CCCCC2)=O)c(ccc(O)c2)c2s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khovidhunkit W, et al. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999;130(5):431-439.
molnova catalog
related products
-
HLM006474
HLM006474 is a pan inhibitor of E2F. This inhibits E2F4 DNA-binding (IC50: 29.8 μM in A375 cells).HLM006474 causes the viability of both SCLC and NSCLC lines (IC50 ranging from 15 to 75 μM). HLM006474 displays little activities against E2F4 DNA-binding in A375 cells at 10 and 20 μM, apparently inhibits E2F4 DNA-binding at 40 μM, and increasingly suppresses the effect at 60 and 80 μM concentrations.
-
LF 20 Consensus Pept...
LF 20 Consensus Peptide. Anthrax Related Lethal Factor
-
Epigerardianin B
Epigerardianin B
